Cargando…

Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations

Based on DFT, MP2, and the density functional from Truhlar group (hybrid GGA: MPW1k) calculations for an acid-catalyzed hydrolysis of nine Kirby's N-alkylmaleamic acids and two atenolol prodrugs were designed. The calculations demonstrated that the amide bond cleavage is due to intramolecular n...

Descripción completa

Detalles Bibliográficos
Autores principales: Karaman, Rafik, Qtait, Alaa, Dajani, Khulod Khayyat, Abu Lafi, Saleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913492/
https://www.ncbi.nlm.nih.gov/pubmed/24526887
http://dx.doi.org/10.1155/2014/248651
_version_ 1782302233005654016
author Karaman, Rafik
Qtait, Alaa
Dajani, Khulod Khayyat
Abu Lafi, Saleh
author_facet Karaman, Rafik
Qtait, Alaa
Dajani, Khulod Khayyat
Abu Lafi, Saleh
author_sort Karaman, Rafik
collection PubMed
description Based on DFT, MP2, and the density functional from Truhlar group (hybrid GGA: MPW1k) calculations for an acid-catalyzed hydrolysis of nine Kirby's N-alkylmaleamic acids and two atenolol prodrugs were designed. The calculations demonstrated that the amide bond cleavage is due to intramolecular nucleophilic catalysis by the adjacent carboxylic acid group and the rate-limiting step is determined based on the nature of the amine leaving group. In addition, a linear correlation of the calculated and experimental rate values has drawn credible basis for designing atenolol prodrugs that are bitterless, are stable in neutral aqueous solutions, and have the potential to release the parent drug in a sustained release manner. For example, based on the calculated B3LYP/6-31 G (d,p) rates, the predicted t (1/2) (a time needed for 50% of the prodrug to be converted into drug) values for atenolol prodrugs ProD 1-ProD 2 at pH 2 were 65.3 hours (6.3 hours as calculated by GGA: MPW1K) and 11.8 minutes, respectively. In vitro kinetic study of atenolol prodrug ProD 1 demonstrated that the t (1/2) was largely affected by the pH of the medium. The determined t (1/2) values in 1N HCl, buffer pH 2, and buffer pH 5 were 2.53, 3.82, and 133 hours, respectively.
format Online
Article
Text
id pubmed-3913492
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-39134922014-02-13 Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations Karaman, Rafik Qtait, Alaa Dajani, Khulod Khayyat Abu Lafi, Saleh ScientificWorldJournal Research Article Based on DFT, MP2, and the density functional from Truhlar group (hybrid GGA: MPW1k) calculations for an acid-catalyzed hydrolysis of nine Kirby's N-alkylmaleamic acids and two atenolol prodrugs were designed. The calculations demonstrated that the amide bond cleavage is due to intramolecular nucleophilic catalysis by the adjacent carboxylic acid group and the rate-limiting step is determined based on the nature of the amine leaving group. In addition, a linear correlation of the calculated and experimental rate values has drawn credible basis for designing atenolol prodrugs that are bitterless, are stable in neutral aqueous solutions, and have the potential to release the parent drug in a sustained release manner. For example, based on the calculated B3LYP/6-31 G (d,p) rates, the predicted t (1/2) (a time needed for 50% of the prodrug to be converted into drug) values for atenolol prodrugs ProD 1-ProD 2 at pH 2 were 65.3 hours (6.3 hours as calculated by GGA: MPW1K) and 11.8 minutes, respectively. In vitro kinetic study of atenolol prodrug ProD 1 demonstrated that the t (1/2) was largely affected by the pH of the medium. The determined t (1/2) values in 1N HCl, buffer pH 2, and buffer pH 5 were 2.53, 3.82, and 133 hours, respectively. Hindawi Publishing Corporation 2014-01-12 /pmc/articles/PMC3913492/ /pubmed/24526887 http://dx.doi.org/10.1155/2014/248651 Text en Copyright © 2014 Rafik Karaman et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Karaman, Rafik
Qtait, Alaa
Dajani, Khulod Khayyat
Abu Lafi, Saleh
Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations
title Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations
title_full Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations
title_fullStr Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations
title_full_unstemmed Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations
title_short Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations
title_sort design, synthesis, and in vitro kinetics study of atenolol prodrugs for the use in aqueous formulations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913492/
https://www.ncbi.nlm.nih.gov/pubmed/24526887
http://dx.doi.org/10.1155/2014/248651
work_keys_str_mv AT karamanrafik designsynthesisandinvitrokineticsstudyofatenololprodrugsfortheuseinaqueousformulations
AT qtaitalaa designsynthesisandinvitrokineticsstudyofatenololprodrugsfortheuseinaqueousformulations
AT dajanikhulodkhayyat designsynthesisandinvitrokineticsstudyofatenololprodrugsfortheuseinaqueousformulations
AT abulafisaleh designsynthesisandinvitrokineticsstudyofatenololprodrugsfortheuseinaqueousformulations